Regeneus secures ethics approval to collect stem cells for off-the-shelf … – Proactive Investors Australia
| Proactive Investors Australia Regenerative medicine company Regeneus (ASX: RGS) has received the key ethics approval to collect stem cells from human donors for the production of its new allogeneic off-the-shelf stem cell product for osteoarthritis. It can now begin manufacturing … Regeneus scores stem cells ethics approvalFinance News Network |
